Background
==========

*Pseudomonas aeruginosa* infections are associated with high mortality. *Ps. aeruginosa* has developed, after many years, multidrug resistance. We conducted a retrospective study to identify risks factors associated with acquisition of MDR *Ps. aeruginosa* in ICU patients.

Methods
=======

A retrospective study was performed in the 12-bed medico-surgical ICU from January to December 2000. All charts corresponding to acquisition of *Ps. aeruginosa* were reviewed; among them, we compare patients with or without a MDR strain. The MDR strains were genotyped by pulsed-field gel electrophoresis (PFGE) and were defined as resistance to at least three drugs among ciprofloxacin (CIP), amikacin, ceftazidim and imipenem.

Results
=======

Six hundred and ninety-nine patients were admitted to the ICU during the study period. Fifty-two (7.5%) had a colonization or an infection with *Ps. aeruginosa* during their ICU stay. Forty (77%) had a susceptible strain and 12 (23%) had a MDR strain. Alcoholism was more frequent in the MDR group (*P* = 0.047). The previous use of CIP, cefuroxime (CEF) and bitherapy with cefepime (CEP) plus amikacin were identified as a risk factor associated with acquisition of a MDR *Ps. aeruginosa* (for CIP, *P* = 0.0012; for CEF, *P* = 0.03; and for bitherapy, *P* = 0.026). No clonal strain was identified by PFGE.

Conclusions
===========

The previous use of some broad-spectrum antibiotics was associated with development of MDR *Ps. aeruginosa*. Control prescriptions and optimizing use of broad-spectrum antibiotics is now established in our hospital to reduce the risk of emergence of MDR strains.
